皮肤BAP1失活黑色素细胞肿瘤的临床与皮肤镜特征:国际皮肤镜学会多中心病例对照研究结果
这项回顾性多中心病例对照研究分析了31例患者共48个活检证实的BAP1失活黑色素细胞肿瘤(BIMT)及80例对照,描述其临床与皮肤镜特征。多数BIMT临床表现为粉色圆顶状丘疹,皮肤镜识别出5种模式,其中结构无区伴偏心性点/球和网络伴隆起结构无区模式仅见于BIMT,且在BAP1胚系突变患者中更常见。
要点
- BIMT多表现为粉色圆顶状丘疹(24/48)。
- 皮肤镜见5种模式,结构无区伴偏心性点/球占29.8%。
- 两种皮肤镜模式仅见于BIMT,且与BAP1胚系突变相关。
核心结论
- 粉色至棕褐色结构无区伴外周不规则点/球或网络的圆顶状丘疹应引起对BIMT的临床怀疑。
研究设计与样本
- 回顾性、多中心、病例对照研究,纳入31例患者共48个活检证实的BIMT和80例对照患者,比较皮肤镜特征。
主要发现
- 48个BIMT来自31例患者(22例女性;中位年龄37岁),80例对照;11例患者有BAP1胚系突变。
- 临床上多数BIMT表现为粉色圆顶状丘疹(n=24)。
- 皮肤镜识别5种模式:结构无区粉色至棕褐色伴不规则偏心性点/球(n=14,29.8%);结构无区粉色至棕褐色伴外周血管(n=10,21.3%);结构无区粉色至棕褐色(n=7,14.9%);网络伴隆起结构无区粉色至棕褐色区域(n=7,14.9%);球状模式(n=4,8.5%)。
- 结构无区伴偏心性点/球模式和网络伴隆起结构无区模式仅见于BIMT,且在BAP1胚系突变患者中更常见(分别为P<.0001和P=.001)。
临床怎么用
- 作者认为,粉色至棕褐色结构无区伴外周不规则点/球或网络的圆顶状丘疹应引起对BIMT的临床怀疑。
局限性
- 样本量小。
- 回顾性设计。
- 并非所有患者均接受胚系基因检测。
- 存在纳入偏倚,倾向于更不典型外观的BIMT。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Multiple BRCA1-associated protein 1 (BAP1)-inactivated melanocytic tumors (BIMTs) have been associated with a familial cancer syndrome involving germline mutations in BAP1. OBJECTIVES: We sought to describe the clinical and dermoscopic features of BIMTs. METHODS: This was a retrospective, multicenter, case-control study. Participating centers contributed clinical data, dermoscopic images, and histopathologic data of biopsy-proven BIMTs. We compared the dermoscopic features between BIMTs and control patients. RESULTS: The dataset consisted of 48 BIMTs from 31 patients (22 women; median age 37 years) and 80 control patients. Eleven patients had a BAP1 germline mutation. Clinically, most BIMTs presented as pink, dome-shaped papules (n = 24). Dermoscopically, we identified 5 patterns: structureless pink-to-tan with irregular eccentric dots/globules (n = 14, 29.8%); structureless pink-to-tan with peripheral vessels (n = 10, 21.3%); structureless pink-to-tan (n = 7, 14.9%); a network with raised, structureless, pink-to-tan areas (n = 7, 14.9%); and globular pattern (n = 4, 8.5%). The structureless with eccentric dots/globules pattern and network with raised structureless areas pattern were only identified in BIMT and were more common in patients with BAP1 germline mutations (P < .0001 and P = .001, respectively). LIMITATIONS: Limitations included our small sample size, retrospective design, the absence of germline genetic testing in all patients, and inclusion bias toward more atypical-looking BIMTs. CONCLUSIONS: Dome-shaped papules with pink-to-tan structureless areas and peripheral irregular dots/globules or network should raise the clinical suspicion for BIMT.
引用
- Yélamos O, Navarrete-Dechent C, Marchetti MA, et al. Clinical and dermoscopic features of cutaneous BAP1-inactivated melanocytic tumors: Results of a multicenter case-control study by the International Dermoscopy Society. J Am Acad Dermatol. 2018. PMID: 30244062. doi:10.1016/j.jaad.2018.09.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。